Is maternal serum creatine kinase actually a marker for early diagnosis of ectopic pregnancy?

Eur J Obstet Gynecol Reprod Biol. 1996 Sep;68(1-2):25-7. doi: 10.1016/0301-2115(96)02446-3.

Abstract

Objective: Our purpose was to investigate whether serum creatine kinase (CK) levels could be used as an early marker of ectopic pregnancy. Student's t-test was used for statistical analysis.

Study design: In a prospective study we therefore measured serum progesterone, beta hCG and CK levels in 30 women with ectopic pregnancies, 30 women with ongoing pregnancies and 30 women with missed abortion.

Results: The mean serum CK concentration for patients with an ectopic pregnancy, ongoing pregnancy, and the women with missed abortion was 81.4 +/- 66.2, 81.5 +/- 40.3, 84.8 +/- 49.3, respectively. No relationship was found between CK level and the location of the pregnancy.

Conclusion: Conversely to the first report of Lavie et al. (Am J Obstet Gynecol 1993; 169: 1149), our data suggest that serum CK level is not discriminative in the early diagnosis of tubal pregnancy.

MeSH terms

  • Abortion, Missed / enzymology
  • Biomarkers / blood*
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Creatine Kinase / blood*
  • Female
  • Humans
  • Pregnancy
  • Pregnancy, Ectopic / diagnosis*
  • Pregnancy, Ectopic / enzymology
  • Progesterone / blood
  • Prospective Studies
  • Reference Values

Substances

  • Biomarkers
  • Chorionic Gonadotropin, beta Subunit, Human
  • Progesterone
  • Creatine Kinase